{"id":51029,"date":"2024-10-15T10:23:18","date_gmt":"2024-10-15T08:23:18","guid":{"rendered":"https:\/\/www.ub.edu\/in2ub\/?p=51029"},"modified":"2024-10-15T10:23:18","modified_gmt":"2024-10-15T08:23:18","slug":"descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures","status":"publish","type":"post","link":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/","title":{"rendered":"Descriuen un nou tractament pel melanoma uveal basat en nanoestructures"},"content":{"rendered":"<p>Uveal melanoma is a highly aggressive intraocular tumour without effective therapeutic options. Now, a study lead by the <u><a href=\"https:\/\/www.ub.edu\/in2ub\/grup-de-recerca\/nanostructured-systems-for-controlled-drug-delivery\/\" target=\"_blank\" rel=\"noopener\" data-auth=\"NotApplicable\" data-linkindex=\"2\">Nanostructured systems for controlled drug delivery<\/a><\/u>\u00a0has shown the potential activity of Melatonin (MEL), a ubiquitously expressed endogenous molecule with oncostatic properties, when loaded into nanostructured lipid carriers (NLC). MEL-NLC displayed anti-inflammatory properties in vivo\u00a0and\u00a0cytotoxic potential in a uveal melanoma cell line\u00a0without affecting non-tumoral cells.\u00a0Preliminary biodistribution results also suggested their ability to reach the posterior segment of the eye, mainly the retina and the ciliary body, positioning them as a promising strategy for uveal melanoma treatment.<\/p>\n<p><strong>Article<\/strong>: <a href=\"https:\/\/doi.org\/10.1016\/j.jddst.2024.106057\" target=\"_blank\" rel=\"noopener\">Melatonin loaded nanostructured lipid carriers for the treatment of uveal melanoma<\/a>. Bonilla-Vidal L.; Espina M.; Garc\u00eda M.L.; Cimino C.; Carbone C.; Baldom\u00e0 L.; Badia J.; Gliszczy\u0144ska A.; Souto E.B.; S\u00e1nchez-L\u00f3pez E. Journal of Drug Delivery Science and Technology, Volume 100, October 2024, Article number 106057<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Uveal melanoma is a highly aggressive intraocular tumour without effective therapeutic options. Now, a study lead by the Nanostructured systems for controlled drug delivery\u00a0has shown the potential activity of Melatonin (MEL), a ubiquitously expressed endogenous molecule with oncostatic properties, when loaded into nanostructured lipid carriers (NLC). MEL-NLC displayed anti-inflammatory properties in vivo\u00a0and\u00a0cytotoxic potential in a&#8230;<\/p>\n","protected":false},"author":2,"featured_media":51025,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Descriuen un nou tractament pel melanoma uveal basat en nanoestructures - IN\u00b2UB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Descriuen un nou tractament pel melanoma uveal basat en nanoestructures - IN\u00b2UB\" \/>\n<meta property=\"og:description\" content=\"Uveal melanoma is a highly aggressive intraocular tumour without effective therapeutic options. Now, a study lead by the Nanostructured systems for controlled drug delivery\u00a0has shown the potential activity of Melatonin (MEL), a ubiquitously expressed endogenous molecule with oncostatic properties, when loaded into nanostructured lipid carriers (NLC). MEL-NLC displayed anti-inflammatory properties in vivo\u00a0and\u00a0cytotoxic potential in a...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/\" \/>\n<meta property=\"og:site_name\" content=\"IN\u00b2UB\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-15T08:23:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ub.edu\/in2ub\/wp-content\/uploads\/2024\/10\/image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1880\" \/>\n\t<meta property=\"og:image:height\" content=\"886\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"IN2UB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"IN2UB\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/\",\"url\":\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/\",\"name\":\"Descriuen un nou tractament pel melanoma uveal basat en nanoestructures - IN\u00b2UB\",\"isPartOf\":{\"@id\":\"https:\/\/www.ub.edu\/in2ub\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ub.edu\/in2ub\/wp-content\/uploads\/2024\/10\/image.jpg\",\"datePublished\":\"2024-10-15T08:23:18+00:00\",\"dateModified\":\"2024-10-15T08:23:18+00:00\",\"author\":{\"@id\":\"https:\/\/www.ub.edu\/in2ub\/#\/schema\/person\/fee647be08dbdfdd1486fbe8067be972\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#primaryimage\",\"url\":\"https:\/\/www.ub.edu\/in2ub\/wp-content\/uploads\/2024\/10\/image.jpg\",\"contentUrl\":\"https:\/\/www.ub.edu\/in2ub\/wp-content\/uploads\/2024\/10\/image.jpg\",\"width\":1880,\"height\":886},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/www.ub.edu\/in2ub\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Descriuen un nou tractament pel melanoma uveal basat en nanoestructures\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ub.edu\/in2ub\/#website\",\"url\":\"https:\/\/www.ub.edu\/in2ub\/\",\"name\":\"IN\u00b2UB\",\"description\":\"Institut de Nanoci\u00e8ncia i Nanotecnologia - Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ub.edu\/in2ub\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ub.edu\/in2ub\/#\/schema\/person\/fee647be08dbdfdd1486fbe8067be972\",\"name\":\"IN2UB\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.ub.edu\/in2ub\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/15350879e1365c6016231f421f771d35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/15350879e1365c6016231f421f771d35?s=96&d=mm&r=g\",\"caption\":\"IN2UB\"},\"url\":\"https:\/\/www.ub.edu\/in2ub\/ca\/author\/in2ub_doc\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Descriuen un nou tractament pel melanoma uveal basat en nanoestructures - IN\u00b2UB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/","og_locale":"ca_ES","og_type":"article","og_title":"Descriuen un nou tractament pel melanoma uveal basat en nanoestructures - IN\u00b2UB","og_description":"Uveal melanoma is a highly aggressive intraocular tumour without effective therapeutic options. Now, a study lead by the Nanostructured systems for controlled drug delivery\u00a0has shown the potential activity of Melatonin (MEL), a ubiquitously expressed endogenous molecule with oncostatic properties, when loaded into nanostructured lipid carriers (NLC). MEL-NLC displayed anti-inflammatory properties in vivo\u00a0and\u00a0cytotoxic potential in a...","og_url":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/","og_site_name":"IN\u00b2UB","article_published_time":"2024-10-15T08:23:18+00:00","og_image":[{"width":1880,"height":886,"url":"https:\/\/www.ub.edu\/in2ub\/wp-content\/uploads\/2024\/10\/image.jpg","type":"image\/jpeg"}],"author":"IN2UB","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"IN2UB","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/","url":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/","name":"Descriuen un nou tractament pel melanoma uveal basat en nanoestructures - IN\u00b2UB","isPartOf":{"@id":"https:\/\/www.ub.edu\/in2ub\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#primaryimage"},"image":{"@id":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ub.edu\/in2ub\/wp-content\/uploads\/2024\/10\/image.jpg","datePublished":"2024-10-15T08:23:18+00:00","dateModified":"2024-10-15T08:23:18+00:00","author":{"@id":"https:\/\/www.ub.edu\/in2ub\/#\/schema\/person\/fee647be08dbdfdd1486fbe8067be972"},"breadcrumb":{"@id":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#primaryimage","url":"https:\/\/www.ub.edu\/in2ub\/wp-content\/uploads\/2024\/10\/image.jpg","contentUrl":"https:\/\/www.ub.edu\/in2ub\/wp-content\/uploads\/2024\/10\/image.jpg","width":1880,"height":886},{"@type":"BreadcrumbList","@id":"https:\/\/www.ub.edu\/in2ub\/ca\/descriuen-un-nou-tractament-pel-melanoma-uveal-basat-en-nanoestructures\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/www.ub.edu\/in2ub\/ca\/"},{"@type":"ListItem","position":2,"name":"Descriuen un nou tractament pel melanoma uveal basat en nanoestructures"}]},{"@type":"WebSite","@id":"https:\/\/www.ub.edu\/in2ub\/#website","url":"https:\/\/www.ub.edu\/in2ub\/","name":"IN\u00b2UB","description":"Institut de Nanoci\u00e8ncia i Nanotecnologia - Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ub.edu\/in2ub\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/www.ub.edu\/in2ub\/#\/schema\/person\/fee647be08dbdfdd1486fbe8067be972","name":"IN2UB","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.ub.edu\/in2ub\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/15350879e1365c6016231f421f771d35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/15350879e1365c6016231f421f771d35?s=96&d=mm&r=g","caption":"IN2UB"},"url":"https:\/\/www.ub.edu\/in2ub\/ca\/author\/in2ub_doc\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/posts\/51029"}],"collection":[{"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/comments?post=51029"}],"version-history":[{"count":1,"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/posts\/51029\/revisions"}],"predecessor-version":[{"id":51030,"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/posts\/51029\/revisions\/51030"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/media\/51025"}],"wp:attachment":[{"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/media?parent=51029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/categories?post=51029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ub.edu\/in2ub\/ca\/wp-json\/wp\/v2\/tags?post=51029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}